Differin Gel approced in Japan for Acne « Nuclear Receptor News

Pages
- About NuclearReceptorCentral
Categories
- Nuclear Receptor (60)
- Uncategorized (23)
Archives

Differin Gel approced in Japan for Acne

Posted on July 17, 2008 by crimsoncanary

Galderma Pharma have announced that Japan’s Ministry of Health, Labor and Welfare has approved Differin(R) Gel 0.1% (adapalene) for the topical treatment for acne vulgaris.

Filed under: Nuclear Receptor | Tagged: Adaferin, adapalene, agonist, Differin, Galderma, RAR beta, Redap, Retinoic acid beta receptor, Shionogi

« Mometasone approved in Japan for Allergic Rhinitis Rosiglitazone prevents mitochondrial dysfunction in huntingtin producing cells »

Leave a Reply